Novo Nordisk is to freeze hiring in an effort to control costs at the drug maker. The halt will apply across all markets and ...

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...

T elemedicine company GoodRx ( GDRX) has been helping Americans find the cheapest way to buy drugs for years. Thanks to a new ...

(06/24 04:24) Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial (06/23 19:25) Abortions Accessed Through Telemedicine Are Growing Despite Legal Challenges (06/23 19:00) ...

New insights into the role of inflammation in cardiovascular disease on mortality and major cardiovascular events in people ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

Novo Nordisk A/S said it has implemented a global hiring freeze as the Danish maker of weight-loss drugs seeks to cut costs ...

Novo Nordisk (NVO) reportedly implemented a global hiring freeze as the Danish drugmaker seeks to cut costs and regain its ...

Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious ...

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

Novo Nordisk, the maker of injectible weight loss drugs Ozempic and Wegovy, says a late-stage trial found that a high-dose oral version of the drug helped overweight adults lose 15 per cent of ...